by Sue Robbins | May 22, 2020 | Migraine
Insufficient response to triptans is associated with poor health-related quality of life (HRQoL) and lower work productivity in migraineurs compared with those who respond well to the medications, according to a study published in The Journal of Headache and Pain....
by Sue Robbins | May 20, 2020 | Miscellaneous
I’ve been pouring over textbooks and treatment guidelines, and these four mood stabilizers keep rising to the top.1-6 None of them are perfect, but each has a unique role in bipolar disorder: Lithium Quetiapine (Seroquel) Lurasidone (Latuda) Lamotrigine (Lamictal)...
by Sue Robbins | May 18, 2020 | Migraine
The FDA has approved Dr. Reddy’s Laboratories’ celecoxib oral solution (Elyxyb) for the treatment of acute migraine in adults with or without aura. Notably, the non-steroidal anti-inflammatory drug (NSAID) was given the go-ahead with a boxed warning related to a risk...
by Sue Robbins | May 7, 2020 | Migraine
(CNN)Waking up with a slight headache that becomes painful enough to hinder daily life is the experience of many who suffer from migraines. But for those on a medication plan, adding a yoga practice to their treatment repertoire may help to reduce the intensity and...
by Sue Robbins | May 6, 2020 | Migraine
Although anecdotal evidence suggests that patients who suffer from migraines often report an increased rate of sleep disturbances, including trouble falling and staying asleep, studies conclusively addressing this issue are lacking. With the hypothesis that migraine...
